Literature DB >> 19724854

Enhanced radiosensitivity of SW480 cells via TRAIL up-regulation mediated by Egr-1 promoter.

Y Hu1, W Ouyang, F Wu, C H Cao, K Wang, Z K Liao, Y H Zhong, F X Zhou, S Q Liu, L Xia, Y F Zhou, C H Xie.   

Abstract

Radiosensitization of cancer cells to irradiation could improve the efficacy of radiotherapy. The early transcriptional factor (Egr-1) promoter induced expression of downstream genes after irradiation. TNF-related apoptosis-inducing ligand (TRAIL) is known to induce apoptosis in malignant cells, but displayed little or no toxicity on normal cells. In this study, we constructed pcDNA3.1-Egr-1-TRAIL (pEgr.1-TRAIL) recombinant plasmid and evaluated its effect on human colon cancer cell line SW480. pEgr.1-TRAIL transfection combined with radiotherapy caused dramatically elevation of TRAIL expression both in mRNA and protein levels, much lower radiobiological parameters in clonogenic assays, accompanied by remarkably increase in apoptosis ratio. Furthermore, pEgr.1-TRAIL transfected cells displayed higher proportion in G0/G1 phase. Our results suggested that pEgr.1-TRAIL can sensitize SW480 cells to radiation, and the radiosensitization is related to cell cycle changes and apoptosis mediated by up-regulation of TRAIL expression. These findings support the potential future application of genetic radiotherapy against carcinoma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19724854     DOI: 10.3892/or_00000498

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  4 in total

1.  Enhanced effects of TRAIL-endostatin-based double-gene-radiotherapy on suppressing growth, promoting apoptosis and inducing cell cycle arrest in vascular endothelial cells.

Authors:  Yanbo Li; Caixia Guo; Zhicheng Wang; Pingsheng Gong; Zhiwei Sun; Shouliang Gong
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-04-20

2.  Expression of Smac induced by the Egr1 promoter enhances the radiosensitivity of breast cancer cells.

Authors:  Z-L Li; S Liang; Z-C Wang; Y-B Li; C-X Guo; F Fang; S-L Gong; C-H Lin
Journal:  Cancer Gene Ther       Date:  2014-03-28       Impact factor: 5.987

3.  Cathepsin L suppression increases the radiosensitivity of human glioma U251 cells via G2/M cell cycle arrest and DNA damage.

Authors:  Qing-qing Zhang; Wen-juan Wang; Jun Li; Neng Yang; Gang Chen; Zhong Wang; Zhong-qin Liang
Journal:  Acta Pharmacol Sin       Date:  2015-06-22       Impact factor: 6.150

4.  ABC294640, a sphingosine kinase 2 inhibitor, enhances the antitumor effects of TRAIL in non-small cell lung cancer.

Authors:  Jie Yang; Chunxu Yang; Shimin Zhang; Zijie Mei; Mingjun Shi; Shaoxing Sun; Liu Shi; Zhihao Wang; Yacheng Wang; Zhenzhen Li; Conghua Xie
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.